In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott buys Biocompatibles' stent business

Executive Summary

Abbott Laboratories is buying UK medical device company Biocompatibles' cardiovascular stent business for $234.5mm in cash. The deal gives Abbott worldwide manufacturing, marketing, development, and distribution rights to the BiodivYsio cardiovascular stent line it has been selling exclusively in the US since 1999, when it licensed the rights from Biocompatibles.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies